Not logged in
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
SaveA first-in-human, phase I study of BPI-371153, a novel small-molecule PD-L1 inhibitor, in advanced solid tumors or recurrent/refractory (r/r) lymphoma
Yang, J.; Yu, Y.; Ren, X.; Zhong, D.; Sun, M.; Wen, Q.; Du, X.; Liu, X.; Shen, Z.; Li, P.; Ding, L.; Shi, Y-K.
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save